CIK 0001504776
- Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800423634
- Phone
- +1 646-847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −50,000 | $16.64 | $832K | 12,177 |
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −4,331 | 11,409 | ||
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −44,703 | 754,581 | ||
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Class B Common Stock 10b5-1 | +49,034 | 4,896,869 | ||
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −26,582 | 4,870,287 | ||
| 2024-06-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −50,000 | 4,820,287 | ||
| 2024-06-07 | WILLIAMS RONALD A Director | Grant or award | +19,724 | 82,056 | ||
| 2024-06-07 | Hunt Andrew Director | Grant or award | +19,724 | 1,913,205 | ||
| 2024-06-07 | Sulzberger Gabrielle Director | Grant or award | +14,793 | 84,024 | ||
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +26,582 | 38,888 | ||
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −26,582 | $16.67 | $443K | 12,306 |
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −4,331 | 11,409 | ||
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −44,703 | 754,581 | ||
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Exercise or conversion · Class B Common Stock 10b5-1 | +49,034 | 6,664,669 | ||
| 2024-06-07 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −26,582 | 6,638,087 | ||
| 2024-06-07 | Raider Jeffrey Jacob Director | Grant or award | +14,793 | 496,465 | ||
| 2024-06-07 | Briggs Teresa Director | Grant or award | +14,793 | 46,255 | ||
| 2024-06-07 | Moon Youngme E Director | Grant or award | +14,793 | 86,942 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion 10b5-1 | +58,455 | $12.35 | $722K | 225,334 |
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −58,455 | $16.51 | $965K | 166,879 |
Page 21 of 59 · 1,167 trades